Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Insmed - 34 Year Stock Price History | INSM

Historical daily share price chart and data for Insmed since 1991 adjusted for splits and dividends. The latest closing stock price for Insmed as of June 13, 2025 is 98.79.
  • The all-time high Insmed stock closing price was 760.00 on December 30, 1991.
  • The Insmed 52-week high stock price is 100.00, which is 1.2% above the current share price.
  • The Insmed 52-week low stock price is 60.40, which is 38.9% below the current share price.
  • The average Insmed stock price for the last 52 weeks is 73.27.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Insmed Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 74.1811 69.9500 98.7870 64.8100 98.7870 43.09%
2024 53.5032 29.9400 79.0100 22.0000 69.0400 122.78%
2023 21.8417 19.1800 31.7400 16.2600 30.9900 55.11%
2022 21.8800 28.1300 28.2100 16.9800 19.9800 -26.65%
2021 30.5951 33.4200 44.3000 22.4600 27.2400 -18.17%
2020 28.2231 23.6600 40.5400 13.6300 33.2900 39.41%
2019 23.3077 13.9700 32.1900 13.9100 23.8800 82.01%
2018 22.6318 32.4600 32.9900 11.6000 13.1200 -57.92%
2017 20.2914 13.0800 31.7800 11.6100 31.1800 135.68%
2016 12.7351 17.2400 17.2400 9.0500 13.2300 -27.11%
2015 20.7534 15.9600 27.5400 14.1600 18.1500 17.32%
2014 15.7275 17.1400 21.5400 11.6500 15.4700 -9.00%
2013 11.2478 6.9600 17.3300 5.7200 17.0000 154.11%
2012 4.3827 3.1500 8.0000 2.7000 6.6900 119.34%
2011 6.4065 6.4000 13.1500 2.6400 3.0500 -51.65%
2010 8.1390 7.7000 12.5000 5.7000 6.3080 -18.08%
2009 9.7689 4.9000 24.7000 4.1500 7.7000 64.71%
2008 6.0865 8.3000 9.1000 3.4990 4.6750 -43.33%
2007 8.8034 9.0000 15.6000 5.7700 8.2500 -6.25%
2006 16.1199 21.3000 31.2000 8.5000 8.8000 -55.33%
2005 12.6981 23.0000 23.0000 8.2000 19.7000 -10.41%
2004 23.1546 30.3000 40.9000 10.1000 21.9900 -25.96%
2003 20.0217 4.8000 34.2000 4.1000 29.7000 561.47%
2002 17.7450 39.4000 39.4000 3.5000 4.4900 -88.25%
2001 45.0065 37.5000 89.9000 24.7000 38.2000 10.12%
2000 166.4676 110.0000 455.0000 26.8750 34.6880 -69.84%
1999 57.0461 67.5000 115.0000 33.7520 115.0000 70.37%
1998 77.4331 70.0000 155.0000 20.0000 67.5000 -6.90%
1997 100.8424 82.5000 155.0000 66.2480 72.5000 -9.38%
1996 101.0310 105.0000 157.5000 72.5000 80.0000 -21.95%
1995 83.9087 102.5000 120.0000 50.0000 102.5000 -2.38%
1994 253.8046 445.0000 460.0000 80.0000 105.0000 -76.14%
1993 319.4862 390.0000 445.0000 230.0000 440.0000 10.00%
1992 358.3858 710.0000 720.0000 210.0000 400.0000 -45.21%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $17.646B $0.364B
Insmed is a biopharmaceutical company engaged in the development and commercialization of ARIKAYCE, or liposomal amikacin for inhalation, for at least two identified orphan patient populations: patients with nontuberculous mycobacteria (NTM) lung infections and cystic fibrosis (CF) patients with Pseudomonas aeruginosa lung infections. Insmed is also focused on the development of INS1009, the company's inhaled treprostinil prodrug for the treatment of pulmonary arterial hypertension (PAH), a chronic, life-threatening disorder characterized by abnormally high blood pressure in the arteries between the heart and lungs.
Stock Name Country Market Cap PE Ratio
AstraZeneca (AZN) United Kingdom $232.596B 17.36
Amgen (AMGN) United States $159.855B 14.32
Gilead Sciences (GILD) United States $139.382B 14.48
Vertex Pharmaceuticals (VRTX) United States $118.142B 0.00
Bristol Myers Squibb (BMY) United States $103.158B 6.91
GSK (GSK) United Kingdom $87.087B 10.41
CSL (CSLLY) Australia $76.641B 0.00
Regeneron Pharmaceuticals (REGN) United States $56.341B 13.68
Alnylam Pharmaceuticals (ALNY) United States $39.725B 0.00
Argenex SE (ARGX) Netherlands $35.827B 97.79
BioNTech SE (BNTX) Germany $25.222B 0.00
Royalty Pharma (RPRX) United States $19.830B 8.38
Biogen (BIIB) United States $19.387B 8.36
Genmab (GNMSF) Denmark $14.821B 15.15
Genmab (GMAB) Denmark $14.806B 16.61
Illumina (ILMN) United States $13.951B 26.47
Incyte (INCY) United States $13.399B 101.79
Exelixis (EXEL) United States $11.394B 19.34
Swedish Orphan Biovitrum (BIOVF) Sweden $11.389B 29.08
BioMarin Pharmaceutical (BMRN) United States $10.985B 17.84
Moderna (MRNA) United States $10.577B 0.00
QIAGEN (QGEN) Netherlands $10.534B 20.50
Ascendis Pharma (ASND) Denmark $10.442B 0.00
Exact Sciences (EXAS) United States $10.188B 0.00
Blueprint Medicines (BPMC) United States $8.280B 0.00
Bio-Techne Corp (TECH) United States $8.078B 30.14
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $7.944B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $7.874B 0.00
Roivant Sciences (ROIV) United Kingdom $7.797B 0.00
Revolution Medicines (RVMD) United States $7.657B 0.00
Repligen (RGEN) United States $7.377B 82.58
Legend Biotech (LEGN) United States $6.966B 0.00
Bio-Rad Laboratories (BIO.B) United States $6.805B 23.68
Halozyme Therapeutics (HALO) United States $6.720B 12.86
Jazz Pharmaceuticals (JAZZ) Ireland $6.674B 6.55
Guardant Health (GH) United States $6.073B 0.00
TG Therapeutics (TGTX) United States $5.933B 155.71
Telix Pharmaceuticals (TLX) Australia $5.903B 0.00
Nuvalent (NUVL) United States $5.595B 0.00
Zealand Pharma (ZLDPF) Denmark $5.265B 0.00
Axsome Therapeutics (AXSM) United States $5.231B 0.00
ADMA Biologics Inc (ADMA) United States $5.157B 38.57
Alkermes (ALKS) Ireland $5.076B 13.62
Zai Lab (ZLAB) China $4.747B 0.00
Vaxcyte (PCVX) United States $4.445B 0.00
Akero Therapeutics (AKRO) United States $4.270B 0.00
Krystal Biotech (KRYS) United States $4.055B 31.25
PTC Therapeutics (PTCT) United States $4.041B 7.03
Rhythm Pharmaceuticals (RYTM) United States $4.009B 0.00
Cytokinetics (CYTK) United States $3.965B 0.00
Avidity Biosciences (RNA) United States $3.874B 0.00
Merus (MRUS) Netherlands $3.834B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.715B 0.00
Sarepta Therapeutics (SRPT) United States $3.667B 0.00
Arcellx (ACLX) United States $3.665B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.638B 31.97
Metsera (MTSR) United States $3.633B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $3.565B 0.00
SpringWorks Therapeutics (SWTX) United States $3.523B 0.00
Protagonist Therapeutics (PTGX) United States $3.491B 75.09
Viking Therapeutics (VKTX) United States $3.210B 0.00
Scholar Rock Holding (SRRK) United States $3.164B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.089B 0.00
Kymera Therapeutics (KYMR) United States $3.080B 0.00
Alvotech (ALVO) Luxembourg $2.967B 16.97
MoonLake Immunotherapeutics (MLTX) Switzerland $2.818B 0.00
ImmunityBio (IBRX) United States $2.816B 0.00
Ascentage Pharma Group - (AAPG) China $2.789B 0.00
Immunovant (IMVT) United States $2.725B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.517B 0.00
Mirum Pharmaceuticals (MIRM) United States $2.428B 0.00
Apellis Pharmaceuticals (APLS) United States $2.421B 0.00
Bavarian Nordic (BVNRY) Denmark $2.245B 11.86
Arrowhead Pharmaceuticals (ARWR) United States $2.240B 0.00
Ligand Pharmaceuticals (LGND) United States $2.208B 0.00
Denali Therapeutics (DNLI) United States $2.168B 0.00
Vericel (VCEL) United States $2.139B 1416.00
NovoCure (NVCR) Jersey $2.029B 0.00
Kiniksa Pharmaceuticals (KNSA) United Kingdom $2.023B 0.00
CG Oncology (CGON) United States $2.020B 0.00
Twist Bioscience (TWST) United States $2.015B 0.00
Agios Pharmaceuticals (AGIO) United States $1.998B 0.00
Belite Bio (BLTE) United States $1.978B 0.00
IDEAYA Biosciences (IDYA) United States $1.951B 0.00
Apogee Therapeutics (APGE) United States $1.928B 0.00
Harmony Biosciences Holdings (HRMY) United States $1.914B 12.72
Amicus Therapeutics (FOLD) United States $1.900B 205.67
Disc Medicine (IRON) United States $1.826B 0.00
Certara (CERT) United States $1.814B 33.88
Immunocore Holdings (IMCR) United Kingdom $1.790B 0.00
Beam Therapeutics (BEAM) United States $1.754B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.720B 0.00
Edgewise Therapeutics (EWTX) United States $1.622B 0.00
Arcutis Biotherapeutics (ARQT) United States $1.609B 0.00
Biohaven (BHVN) United States $1.592B 0.00
Adaptive Biotechnologies (ADPT) United States $1.581B 0.00
Mesoblast (MESO) Australia $1.554B 0.00
BGM Group (BGM) China $1.518B 0.00
Janux Therapeutics (JANX) United States $1.513B 0.00
GRAIL (GRAL) United States $1.508B 0.00
Vera Therapeutics (VERA) United States $1.436B 0.00
89BIO (ETNB) United States $1.404B 0.00
Celldex Therapeutics (CLDX) United States $1.351B 0.00
ANI Pharmaceuticals (ANIP) United States $1.346B 13.87
Travere Therapeutics (TVTX) United States $1.327B 0.00
Viridian Therapeutics (VRDN) United States $1.279B 0.00
Structure Therapeutics (GPCR) United States $1.274B 0.00
Anbio Biotechnology (NNNN) Germany $1.266B 0.00
CureVac (CVAC) Germany $1.256B 6.09
Dynavax Technologies (DVAX) United States $1.249B 74.29
Liquidia Technologies (LQDA) United States $1.235B 0.00
MannKind (MNKD) United States $1.164B 23.94
Novavax (NVAX) United States $1.158B 2.70
Pacira BioSciences (PCRX) United States $1.132B 10.77
Niagen Bioscience (NAGE) United States $1.114B 157.11
WAVE Life Sciences (WVE) Singapore $1.110B 0.00
Spyre Therapeutics (SYRE) United States $1.067B 0.00
CorMedix Inc (CRMD) United States $1.008B 67.54
Geron (GERN) United States $0.994B 0.00
Arcus Biosciences (RCUS) United States $0.990B 0.00
Mineralys Therapeutics (MLYS) United States $0.972B 0.00
NeoGenomics (NEO) United States $0.951B 0.00
AbCellera Biologics (ABCL) Canada $0.940B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.918B 0.00
Praxis Precision Medicines (PRAX) United States $0.917B 0.00
Nurix Therapeutics (NRIX) United States $0.912B 0.00
Zymeworks (ZYME) United States $0.911B 0.00
MiMedx (MDXG) United States $0.904B 21.86
Pharvaris (PHVS) Netherlands $0.901B 0.00
UniQure (QURE) Netherlands $0.876B 0.00
Intellia Therapeutics (NTLA) United States $0.865B 0.00
Oculis Holding AG (OCS) Switzerland $0.859B 0.00
Immunome (IMNM) United States $0.852B 0.00
LENZ Therapeutics (LENZ) United States $0.833B 0.00
Oric Pharmaceuticals (ORIC) United States $0.824B 0.00
Cogent Biosciences (COGT) United States $0.822B 0.00
ArriVent BioPharma (AVBP) United States $0.808B 0.00
Pharming Group (PHGUF) Netherlands $0.795B 0.00
Pharming Group (PHAR) Netherlands $0.787B 0.00
Iovance Biotherapeutics (IOVA) United States $0.771B 0.00
Replimune (REPL) United States $0.762B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.760B 0.00
Gyre Therapeutics (GYRE) United States $0.757B 201.75
Sionna Therapeutics (SION) United States $0.750B 0.00
Immatics (IMTX) Germany $0.746B 0.00
Trevi Therapeutics (TRVI) United States $0.724B 0.00
Vir Biotechnology (VIR) United States $0.722B 0.00
Anavex Life Sciences (AVXL) United States $0.702B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.700B 0.00
AnaptysBio (ANAB) United States $0.688B 0.00
Arbutus Biopharma (ABUS) United States $0.686B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.678B 0.00
GH Research (GHRS) Ireland $0.668B 0.00
Stoke Therapeutics (STOK) United States $0.645B 14.96
Sinovac Biotech (SVA) China $0.645B 0.00
Bicara Therapeutics (BCAX) United States $0.631B 0.00
Upstream Bio (UPB) United States $0.622B 0.00
Dianthus Therapeutics (DNTH) United States $0.620B 0.00
Nuvation Bio (NUVB) United States $0.616B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.610B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.602B 0.00
Maze Therapeutics (MAZE) United States $0.593B 0.00
Kura Oncology (KURA) United States $0.577B 0.00
Sana Biotechnology (SANA) United States $0.573B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.572B 0.00
Fortrea Holdings (FTRE) United States $0.567B 15.68
Keros Therapeutics (KROS) United States $0.554B 0.00
Arvinas (ARVN) United States $0.553B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.552B 0.00
Tyra Biosciences (TYRA) United States $0.548B 0.00
Tango Therapeutics (TNGX) United States $0.547B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.544B 0.00
Castle Biosciences (CSTL) United States $0.543B 36.90
MeiraGTx Holdings (MGTX) United States $0.530B 0.00
Cullinan Therapeutics (CGEM) United States $0.528B 0.00
Opthea (OPT) Australia $0.525B 0.00
REGENXBIO (RGNX) United States $0.512B 0.00
Urogen Pharma (URGN) United States $0.511B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.494B 0.00
ATyr Pharma (ATYR) United States $0.483B 0.00
Myriad Genetics (MYGN) United States $0.478B 0.00
Celcuity (CELC) United States $0.476B 0.00
Zenas BioPharma (ZBIO) United States $0.474B 0.00
PureTech Health (PRTC) United States $0.471B 0.00
Septerna (SEPN) United States $0.464B 0.00
Precigen (PGEN) United States $0.449B 0.00
Abivax SA (ABVX) France $0.445B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.442B 0.00
Erasca (ERAS) United States $0.433B 0.00
Cytek Biosciences (CTKB) United States $0.426B 0.00
Tectonic Therapeutic (TECX) United States $0.419B 0.00
Benitec Biopharma (BNTC) United States $0.418B 0.00
Sage Therapeutics (SAGE) United States $0.413B 0.00
Rapport Therapeutics (RAPP) United States $0.407B 0.00
Kamada (KMDA) Israel $0.399B 23.93
Eton Pharmaceuticals (ETON) United States $0.389B 0.00
ITeos Therapeutics (ITOS) United States $0.382B 0.00
Northwest Biotherapeutics (NWBO) United States $0.378B 0.00
Rezolute (RZLT) United States $0.376B 0.00
Humacyte (HUMA) United States $0.374B 0.00
Checkpoint Therapeutics (CKPT) United States $0.371B 0.00
Vigil Neuroscience (VIGL) United States $0.367B 0.00
Fulcrum Therapeutics (FULC) United States $0.366B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.364B 0.00
Absci (ABSI) United States $0.362B 0.00
MBX Biosciences (MBX) United States $0.358B 0.00
Emergent Biosolutions (EBS) United States $0.358B 0.00
Solid Biosciences (SLDB) United States $0.355B 0.00
Ocugen (OCGN) United States $0.350B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.344B 0.00
Terns Pharmaceuticals (TERN) United States $0.343B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.343B 0.00
Aura Biosciences (AURA) United States $0.335B 0.00
Compass Therapeutics (CMPX) United States $0.333B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.328B 0.00
Inventiva S.A (IVA) France $0.325B 0.00
Verastem (VSTM) United States $0.323B 0.00
Abeona Therapeutics (ABEO) United States $0.319B 0.00
Astria Therapeutics (ATXS) United States $0.316B 0.00
Alpha Teknova (TKNO) United States $0.310B 0.00
Allogene Therapeutics (ALLO) United States $0.306B 0.00
Cidara Therapeutics (CDTX) United States $0.304B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.303B 61.50
Entrada Therapeutics (TRDA) United States $0.298B 9.69
Annexon (ANNX) United States $0.297B 0.00
XOMA Royalty (XOMA) United States $0.294B 0.00
Palvella Therapeutics (PVLA) United States $0.292B 0.00
Neurogene (NGNE) United States $0.291B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.289B 0.00
Gossamer Bio (GOSS) United States $0.289B 0.00
Olema Pharmaceuticals (OLMA) United States $0.278B 0.00
Amarin (AMRN) Ireland $0.277B 0.00
Atea Pharmaceuticals (AVIR) United States $0.275B 0.00
Prothena (PRTA) Ireland $0.273B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.273B 0.00
Candel Therapeutics (CADL) United States $0.269B 0.00
2seventy Bio (TSVT) United States $0.266B 0.00
Cartesian Therapeutics (RNAC) United States $0.266B 0.00
DBV Technologies S.A (DBVT) France $0.265B 0.00
Sagimet Biosciences (SGMT) United States $0.264B 0.00
Inozyme Pharma (INZY) United States $0.257B 0.00
Foghorn Therapeutics (FHTX) United States $0.253B 0.00
Lifecore Biomedical (LFCR) United States $0.253B 0.00
Prima BioMed (IMMP) Australia $0.253B 0.00
Cardiff Oncology (CRDF) United States $0.252B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.252B 0.00
Instil Bio (TIL) United States $0.246B 0.00
Tvardi Therapeutics (TVRD) United States $0.244B 0.00
Third Harmonic Bio (THRD) United States $0.244B 0.00
MaxCyte (MXCT) United States $0.242B 0.00
CytomX Therapeutics (CTMX) United States $0.241B 6.23
Aardvark Therapeutics (AARD) United States $0.240B 0.00
Semper Paratus Acquisition (TVGN) United States $0.234B 0.00
BioStem Technologies (BSEM) $0.232B 9.46
Adherex Technologies (FENC) United States $0.230B 0.00
ACELYRIN, INC (SLRN) United States $0.229B 0.00
Design Therapeutics (DSGN) United States $0.222B 0.00
Adocia (ADOCY) France $0.213B 0.00
ScPharmaceuticals (SCPH) United States $0.211B 0.00
I-Mab (IMAB) United States $0.211B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.210B 0.00
AC Immune (ACIU) Switzerland $0.208B 0.00
Inhibrx Biosciences (INBX) United States $0.207B 0.12
Monopar Therapeutics (MNPR) United States $0.207B 0.00
CARGO Therapeutics (CRGX) United States $0.207B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.204B 0.00
GENFIT S.A (GNFT) France $0.201B 0.00
Bright Minds Biosciences (DRUG) United States $0.200B 0.00
Voyager Therapeutics (VYGR) United States $0.199B 0.00
Kodiak Sciences (KOD) United States $0.194B 0.00
Prime Medicine (PRME) United States $0.192B 0.00
Codexis (CDXS) United States $0.186B 0.00
Nuvectis Pharma (NVCT) United States $0.184B 0.00
Editas Medicine (EDIT) United States $0.182B 0.00
Innate Pharma S.A (IPHA) France $0.182B 0.00
INmune Bio (INMB) United States $0.182B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.180B 0.00
Ventyx Biosciences (VTYX) United States $0.177B 0.00
Puma Biotechnology (PBYI) United States $0.177B 4.62
Actuate Therapeutics (ACTU) United States $0.169B 0.00
DiaMedica Therapeutics (DMAC) United States $0.167B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.166B 0.00
EnGene Holdings (ENGN) Canada $0.166B 0.00
Galena Biopharma (SLS) United States $0.165B 0.00
Alector (ALEC) United States $0.162B 0.00
Anika Therapeutics (ANIK) United States $0.162B 0.00
Spero Therapeutics (SPRO) United States $0.162B 0.00
BioAge Labs (BIOA) United States $0.161B 0.00
Fate Therapeutics (FATE) United States $0.160B 0.00
Molecular Partners AG (MOLN) Switzerland $0.157B 0.00
Alpha Cognition (ACOG) Canada $0.154B 0.00
Alumis (ALMS) United States $0.150B 0.00
Kyverna Therapeutics (KYTX) United States $0.150B 0.00
Compugen (CGEN) Israel $0.148B 0.00
Neumora Therapeutics (NMRA) United States $0.145B 0.00
Rapt Therapeutics (RAPT) United States $0.144B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.140B 0.00
Black Diamond Therapeutics (BDTX) United States $0.138B 40.50
23andMe Holding (MEHCQ) United States $0.138B 0.00
Nkarta (NKTX) United States $0.136B 0.00
Agenus (AGEN) United States $0.132B 0.00
Elicio Therapeutics (ELTX) United States $0.128B 0.00
Greenwich LifeSciences (GLSI) United States $0.127B 0.00
BioHarvest Sciences (BHST) Canada $0.126B 0.00
Seer (SEER) United States $0.125B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.121B 0.00
Contineum Therapeutics (CTNM) United States $0.120B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.119B 0.00
Sangamo Therapeutics (SGMO) United States $0.117B 0.00
Theratechnologies (THTX) Canada $0.116B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.116B 0.00
C4 Therapeutics (CCCC) United States $0.115B 0.00
TuHURA Biosciences (HURA) United States $0.114B 0.00
BeyondSpring (BYSI) United States $0.114B 0.00
EXoZymes (EXOZ) United States $0.110B 0.00
Caribou Biosciences (CRBU) United States $0.108B 0.00
Citius Oncology (CTOR) United States $0.105B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.105B 0.00
Invivyd (IVVD) United States $0.102B 0.00
Genelux (GNLX) United States $0.100B 0.00
IO Biotech (IOBT) Denmark $0.099B 0.00
Biomea Fusion (BMEA) United States $0.098B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.098B 0.00
Tenaya Therapeutics (TNYA) United States $0.098B 0.00
HilleVax (HLVX) United States $0.096B 0.00
Whitehawk Therapeutics (WHWK) United States $0.096B 0.00
Entera Bio (ENTX) Israel $0.095B 0.00
Adagene (ADAG) China $0.092B 0.00
Coherus Oncology (CHRS) United States $0.092B 0.00
Cabaletta Bio (CABA) United States $0.091B 0.00
TScan Therapeutics (TCRX) United States $0.091B 0.00
Pliant Therapeutics (PLRX) United States $0.090B 0.00
Nautilus Biotechnology (NAUT) United States $0.090B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.090B 0.00
Coya Therapeutics (COYA) United States $0.090B 0.00
Climb Bio (CLYM) United States $0.087B 0.00
OKYO Pharma (OKYO) $0.086B 0.00
XBiotech (XBIT) United States $0.084B 0.00
Jasper Therapeutics (JSPR) United States $0.084B 0.00
Zura Bio (ZURA) United States $0.083B 0.00
Forte Biosciences (FBRX) United States $0.083B 0.00
PDS Biotechnology (PDSB) United States $0.082B 0.00
Immunic (IMUX) United States $0.081B 0.00
Elutia (ELUT) United States $0.078B 0.00
Inovio Pharmaceuticals (INO) United States $0.076B 0.00
Cellectis S.A (CLLS) France $0.076B 0.00
Senti Biosciences (SNTI) United States $0.075B 0.00
TELA Bio (TELA) United States $0.073B 0.00
IGM Biosciences (IGMS) United States $0.072B 0.00
Genenta Science S.p.A (GNTA) Italy $0.071B 0.00
Immuneering (IMRX) United States $0.071B 0.00
Seres Therapeutics (MCRB) United States $0.070B 0.00
Immix Biopharma (IMMX) United States $0.069B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.069B 0.00
Sutro Biopharma (STRO) United States $0.069B 0.00
MediciNova (MNOV) United States $0.068B 0.00
Skye Bioscience (SKYE) United States $0.067B 0.00
VistaGen Therapeutics (VTGN) United States $0.067B 0.00
Alto Neuroscience (ANRO) United States $0.066B 0.00
CervoMed (CRVO) United States $0.066B 0.00
Ikena Oncology (IKNA) United States $0.066B 0.00
Renovaro (RENB) United States $0.065B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.065B 0.00
Adicet Bio (ACET) United States $0.065B 0.00
Akoya Biosciences (AKYA) United States $0.063B 0.00
Clearside Biomedical (CLSD) United States $0.063B 0.00
Repare Therapeutics (RPTX) Canada $0.062B 0.00
Oncobiologics (OTLK) United States $0.062B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.061B 0.00
Opus Genetics (IRD) United States $0.059B 0.00
Adlai Nortye (ANL) Cayman Islands $0.059B 0.00
Fortress Biotech (FBIO) United States $0.058B 0.00
Werewolf Therapeutics (HOWL) United States $0.058B 0.00
Annovis Bio (ANVS) United States $0.057B 0.00
Exicure (XCUR) United States $0.057B 0.00
Precision BioSciences (DTIL) United States $0.056B 0.00
Quince Therapeutics (QNCX) United States $0.055B 0.00
Adverum Biotechnologies (ADVM) United States $0.054B 0.00
Kronos Bio (KRON) United States $0.054B 0.00
InflaRx (IFRX) Germany $0.054B 0.00
ZIVO Bioscience (ZIVO) United States $0.053B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.052B 0.00
Atara Biotherapeutics (ATRA) United States $0.052B 0.00
Applied Therapeutics (APLT) United States $0.052B 0.00
Kalaris Therapeutics (KLRS) United States $0.052B 0.00
Quantum Biopharma (QNTM) Canada $0.051B 0.00
Shattuck Labs (STTK) United States $0.051B 0.00
VTv Therapeutics (VTVT) United States $0.051B 0.00
Oncolytics Biotech (ONCY) Canada $0.050B 0.00
Artiva Biotherapeutics (ARTV) United States $0.050B 0.00
RenovoRx (RNXT) United States $0.050B 0.00
Aligos Therapeutics (ALGS) United States $0.049B 0.00
Bluebird Bio (BLUE) United States $0.049B 0.00
PepGen (PEPG) United States $0.048B 0.00
Cue Biopharma (CUE) United States $0.048B 0.00
Connect Biopharma Holdings (CNTB) United States $0.047B 0.00
Mersana Therapeutics (MRSN) United States $0.045B 0.00
Rein Therapeutics (RNTX) United States $0.044B 0.00
Celularity (CELU) United States $0.042B 0.00
Alterity Therapeutics - (ATHE) Australia $0.041B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.040B 0.00
Radiopharm Theranostics - (RADX) Australia $0.040B 0.00
OnKure Therapeutics (OKUR) United States $0.039B 0.00
Medicus Pharma (MDCX) United States $0.038B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.038B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.037B 0.00
Clene (CLNN) United States $0.037B 0.00
Estrella Immunopharma (ESLA) United States $0.037B 0.00
Scilex Holding (SCLX) United States $0.036B 0.00
Xilio Therapeutics (XLO) United States $0.035B 0.00
Kezar Life Sciences (KZR) United States $0.035B 0.00
Lantern Pharma (LTRN) United States $0.035B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.034B 0.00
AN2 Therapeutics (ANTX) United States $0.034B 0.00
Pluri (PLUR) Israel $0.034B 0.00
FibroBiologics (FBLG) United States $0.033B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.033B 0.00
Rani Therapeutics Holdings (RANI) United States $0.032B 0.00
CAMP4 Therapeutics (CAMP) United States $0.032B 0.00
ABVC BioPharma (ABVC) United States $0.031B 0.00
MiNK Therapeutics (INKT) United States $0.030B 0.00
Allakos (ALLK) United States $0.030B 0.00
Grace Therapeutics (GRCE) Canada $0.030B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.030B 0.00
Cadrenal Therapeutics (CVKD) United States $0.029B 0.00
Curis (CRIS) United States $0.029B 0.00
ALX Oncology Holdings (ALXO) United States $0.029B 0.00
KALA BIO (KALA) United States $0.029B 0.00
Imunon (IMNN) United States $0.028B 0.00
Dyadic (DYAI) United States $0.028B 0.00
Dare Bioscience (DARE) United States $0.028B 0.00
Passage Bio (PASG) United States $0.027B 0.00
Vor Biopharma (VOR) $0.026B 0.00
Generation Bio (GBIO) United States $0.026B 0.00
BioAtla (BCAB) United States $0.025B 0.00
CalciMedica (CALC) United States $0.024B 0.00
Boundless Bio (BOLD) United States $0.024B 0.00
Tenax Therapeutics (TENX) United States $0.024B 0.00
Femasys (FEMY) United States $0.024B 0.00
Chemomab Therapeutics (CMMB) Israel $0.023B 0.00
Elevation Oncology (ELEV) United States $0.023B 0.00
Lisata Therapeutics (LSTA) United States $0.022B 0.00
Gelteq (GELS) Australia $0.022B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.021B 0.00
Q32 Bio (QTTB) United States $0.021B 0.00
Advanced Biomed (ADVB) United States $0.021B 0.00
Ovid Therapeutics (OVID) United States $0.021B 0.00
Longeveron (LGVN) United States $0.020B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.019B 0.00
Cognition Therapeutics (CGTX) United States $0.019B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.019B 0.00
Hoth Therapeutics (HOTH) United States $0.019B 0.00
Cingulate (CING) United States $0.019B 0.00
NextCure (NXTC) United States $0.018B 0.00
Lexaria Bioscience (LEXX) Canada $0.018B 0.00
X4 Pharmaceuticals (XFOR) United States $0.018B 0.00
Leap Therapeutics (LPTX) United States $0.018B 0.00
GeoVax Labs (GOVX) United States $0.017B 0.00
HOOKIPA Pharma (HOOK) United States $0.017B 0.00
IBio (IBIO) United States $0.017B 0.00
SAB Biotherapeutics (SABS) United States $0.017B 0.00
Promis Neurosciences (PMN) Canada $0.017B 0.00
Beyond Air (XAIR) United States $0.016B 0.00
Biorestorative Therapies (BRTX) United States $0.015B 0.00
UNITY Biotechnology (UBX) United States $0.015B 0.00
MetaVia (MTVA) United States $0.015B 0.00
Synlogic (SYBX) United States $0.014B 0.00
Abpro Holdings (ABP) United States $0.014B 0.00
Equillium (EQ) United States $0.014B 0.00
Rallybio (RLYB) United States $0.014B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.013B 0.00
BRIACELL THERAP (BCTX) Canada $0.013B 0.00
Allarity Therapeutics (ALLR) United States $0.013B 0.00
Bionano Genomics (BNGO) United States $0.012B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.012B 0.00
Athira Pharma (ATHA) United States $0.012B 0.00
Aytu BioPharma (AYTU) United States $0.012B 0.00
Bolt Biotherapeutics (BOLT) United States $0.012B 0.00
BioCardia (BCDA) United States $0.011B 0.00
COSCIENS Biopharma (CSCI) Canada $0.011B 0.00
BioXcel Therapeutics (BTAI) United States $0.011B 0.00
Aprea Therapeutics (APRE) United States $0.011B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
Cyclerion Therapeutics (CYCN) United States $0.010B 0.00
Dogwood Therapeutics (DWTX) United States $0.010B 0.00
Novogen (KZIA) Australia $0.010B 0.00
Moleculin Biotech (MBRX) United States $0.009B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.009B 0.00
LakeShore Biopharma (LSB) China $0.009B 0.00
GENPREX (GNPX) United States $0.009B 0.00
BioAffinity Technologies (BIAF) United States $0.009B 0.00
Sensei Biotherapeutics (SNSE) United States $0.008B 0.00
Turnstone Biologics (TSBX) United States $0.008B 0.00
Evogene (EVGN) Israel $0.008B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.008B 0.00
HCW Biologics (HCWB) United States $0.008B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.008B 0.00
Eyenovia (EYEN) United States $0.008B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.008B 0.00
Apollomics (APLM) United States $0.008B 0.00
GT Biopharma (GTBP) United States $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.007B 0.00
IN8bio (INAB) United States $0.007B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.007B 0.00
Mainz Biomed (MYNZ) Germany $0.007B 0.00
Synaptogenix (SNPX) United States $0.007B 0.00
Arcadia Biosciences (RKDA) United States $0.007B 0.00
Portage Biotech (PRTG) $0.007B 0.00
Pasithea Therapeutics (KTTA) United States $0.006B 0.00
Biofrontera (BFRI) United States $0.006B 0.00
Soligenix (SNGX) United States $0.006B 0.00
Intensity Therapeutics (INTS) United States $0.006B 0.00
Jade Biosciences (JBIO) United States $0.006B 0.00
Avalon GloboCare (ALBT) United States $0.006B 0.00
180 Life Sciences (ATNF) United States $0.006B 0.00
Polyrizon (PLRZ) Israel $0.006B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.006B 0.00
Mustang Bio (MBIO) United States $0.006B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
CNS Pharmaceuticals (CNSP) United States $0.005B 0.00
Onconetix (ONCO) United States $0.005B 0.00
Dermata Therapeutics (DRMA) United States $0.005B 0.00
VivoSim Labs (VIVS) United States $0.005B 0.00
Galecto (GLTO) Denmark $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Artelo Biosciences (ARTL) United States $0.004B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.004B 0.00
Tharimmune (THAR) United States $0.004B 0.00
Adial Pharmaceuticals (ADIL) United States $0.004B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.004B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.003B 0.00
Palisade Bio (PALI) United States $0.003B 0.00
Purple Biotech (PPBT) Israel $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.003B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
GRI Bio (GRI) United States $0.003B 0.00
Affimed (AFMD) Germany $0.003B 0.00
Bone Biologics (BBLG) United States $0.003B 0.00
Silo Pharma (SILO) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
Entero Therapeutics (ENTO) United States $0.003B 0.00
Alzamend Neuro (ALZN) United States $0.003B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
NuCana (NCNA) United Kingdom $0.001B 0.00
Revelation Biosciences (REVB) United States $0.001B 0.00
Capstone Holding� (CAPS) United States $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Cocrystal Pharma (COCP) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00